Acute myeloid leukemia M3 has a cure rate of more than 95%, and most cures do not affect life expectancy. Acute myeloid leukemia type M3 is acute promyelocytic leukemia, which is mainly caused by thrombocytopenia and coagulation dysfunction. Its symptoms are intracranial hemorrhage, respiratory difficulties, which can lead to coma or death in severe cases. 1. AML type M3 patients can be cured by injecting sodium arsenite chloride injection and taking medicines such as retinoic acid tablets. It is the only type of AML that can be cured without bone marrow transplantation. 2. Of course, we can’t rule out the possibility of further deterioration of the condition of a few AML type M3 patients, and patients should actively cooperate with the doctor in using medication and chemotherapy in order to better ensure the survival rate. Patients with AML type M3 need to consult the doctor in time and receive medication under the doctor’s guidance. Usually, the life expectancy of cured patients with type M3 is not affected, but the medication should be taken in accordance with the doctor’s instructions, and the patients should also cooperate with the doctor in time to do the checkups during the period, so as to avoid the recurrence of the cancer.